Paid Clinical Trials Augusta

Discover 180 paid clinical trials in Augusta, Maine. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 180

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With OsteosarcomaThoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

Recruiting

PHASE3

Sponsor:

Children's Oncology Group

Location:

Scarborough ME, Bangor ME, Sherbrooke, Lebanon NHshow 144 more

Code:

NCT05235165

Conditions

Metastatic Malignant Neoplasm in the Lung

Metastatic Osteosarcoma

Osteosarcoma

Eligibility Criteria

Sex: All

Age: 0 - 50

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Computed Tomography

Questionnaire Administration

Thoracoscopy

Thoracotomy

Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic LeukemiaFixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia

Recruiting

PHASE2

Sponsor:

Inhye Ahn

Location:

Scarborough ME, Boston MA

Code:

NCT06333262

Conditions

Chronic Lymphocytic Leukemia

Small Lymphocytic Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pirtobrutinib

Obinutuzumab

Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

Recruiting

PHASE3

Sponsor:

Alexion Pharmaceuticals, Inc.

Location:

Augusta ME, Boston MA, Albany NY, East Setauket NYshow 35 more

Code:

NCT06291376

Conditions

Immunoglobulin A Nephropathy

IgAN

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ravulizumab

Placebo

Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid ArthritisStudy to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis

Recruiting

PHASE3

Sponsor:

AbbVie

Location:

Portland ME, Lebanon NH, Boston MA, Sainte-foyshow 77 more

Code:

NCT05814627

Conditions

Rheumatoid Arthritis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Upadacitinib

Adalimumab

Upadacitinib Matching Placebo

Adalimumab Matching Placebo

Micronutrients as Adjunctive Treatment for Bipolar DisorderMicronutrients as Adjunctive Treatment for Bipolar Disorder

Recruiting

Sponsor:

Eastern Maine Medical Center

Location:

Bangor ME

Code:

NCT03541031

Conditions

Bipolar Disorder

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Micronutrient & Fish oil

Olive oil & Safflower oil

Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast CancerOpen-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer

Recruiting

PHASE1

PHASE2

Sponsor:

Stemline Therapeutics, Inc.

Location:

Scarborough ME, Boston MA, Providence RI, New Haven CTshow 37 more

Code:

NCT05563220

Conditions

Breast Cancer

Metastatic Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Elacestrant

Alpelisib

Everolimus

Ribociclib

Palbociclib

Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial CarcinomaSelinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma

Recruiting

PHASE3

Sponsor:

Karyopharm Therapeutics Inc

Location:

Scarborough ME, Boston MA, Montreal, Albany NYshow 71 more

Code:

NCT05611931

Conditions

Endometrial Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Selinexor

Matching Placebo for selinexor

Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular LymphomaStudy of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma

Recruiting

PHASE3

Sponsor:

Genmab

Location:

Scarborough ME, Troy NY, Albany NY, Westbury NYshow 33 more

Code:

NCT06191744

Conditions

Follicular Lymphoma (FL)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Epcoritamab

Prednisone

Rituximab

Lenalidomide

Doxorubicin

Colon Adjuvant Chemotherapy Based on Evaluation of Residual DiseaseColon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Recruiting

PHASE2

PHASE3

Sponsor:

NRG Oncology

Location:

Augusta ME, South Portland ME, Biddeford ME, Sanford MEshow 670 more

Code:

NCT05174169

Conditions

Stage III Colon Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Signatera test

mFOLFOX6 3-6 month

CAPOX 3 month

mFOLFIRINOX

mFOLFOX6 6 month

Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by SurgeryObservation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Bath ME, Portland ME, Scarborough ME, Sanford MEshow 159 more

Code:

NCT03180268

Conditions

Grade 2 Meningioma

Intracranial Meningioma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Clinical Observation

Intensity-Modulated Radiation Therapy

Laboratory Biomarker Analysis

Magnetic Resonance Imaging